CD4 and breast cancer: When controlling for this variable, the higher count of CD8+ NA T cells and the greater proportion of HLA-DR+ CD4+ CM, total CD8+ T cells and CD8+ EMRA cells among breast cancer survivors compared to healthy women was no longer statistically significant.